Kazia Therapeutics Limited (KZIA)
USD 2.85
(-16.18%)
USD 2.85
(-16.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.15 Million | -22.76 Million | -9.11 Million | -8.81 Million | -6.71 Million | -8.66 Million |
| Net Income | -20.46 Million | -24.64 Million | -8.42 Million | -12.46 Million | -10.27 Million | -6.03 Million |
| Depreciation & Amortization | 1.86 Million | 1.95 Million | 1.26 Million | 1.08 Million | 1.08 Million | 1.54 Million |
| Deferred income taxes | -4.6 Million | - | 4.39 Million | 168 Thousand | 1.81 Million | 3.97 Million |
| Stock-based compensation | 1.15 Million | 1.67 Million | 637 Thousand | 262 Thousand | 246 Thousand | 165 Thousand |
| Change in working capital | 3.44 Million | -104 Thousand | -5.02 Million | 1.66 Million | 353 Thousand | 1.53 Million |
| Other non-cash items | 3.43 Million | -1.63 Million | -1.95 Million | 474 Thousand | 62 Thousand | -9.84 Million |
| Investing Cash Flow | - | -2.36 Million | - | - | 2.35 Million | 150 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | -2.36 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 2.35 Million | - |
| Other Investing Activities | - | 268.00 | - | - | 2.35 Million | 150 Thousand |
| Financing Cash Flow | 12.97 Million | 3.72 Million | 28.1 Million | 12.14 Million | 3.81 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.97 Million | 3.72 Million | 28.1 Million | 12.97 Million | 3.81 Million | - |
| Other Financing Activities | -3.00 | 3.72 Million | -152.00 | -833 Thousand | 3.81 Million | - |
| Accounts receivables | 3.44 Million | -6000.00 | -5.02 Million | 358 Thousand | 825 Thousand | 1.72 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7000.00 | -98 Thousand | -392 Thousand | 1.31 Million | -472 Thousand | -188 Thousand |
| Cash at beginning of period | 7.36 Million | 27.58 Million | 8.76 Million | 5.43 Million | 5.95 Million | 14.45 Million |
| Cash at end of period | 5.24 Million | 7.36 Million | 27.58 Million | 8.76 Million | 5.43 Million | 5.95 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 64.24 Thousand | 1.17 Million | -175.61 Thousand | - | 17 Thousand | 12 Thousand |
| Net cash flow / Change in cash | -2.11 Million | -20.22 Million | 18.82 Million | 3.33 Million | -522 Thousand | -8.49 Million |
| Free Cash Flow | -15.15 Million | -22.76 Million | -9.11 Million | -8.81 Million | -6.71 Million | -8.66 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.82 Million | -20.46 Million | -6.87 Million | -13.58 Million | -6.79 Million | -24.64 Million |
| Depreciation & Amortization | 934.7 Thousand | 1.86 Million | 934.71 Thousand | 934.74 Thousand | 467.37 Thousand | 1.95 Million |
| Deferred income taxes | - | -4.6 Million | -2.15 Million | -147.28 Thousand | -147.28 Thousand | - |
| Stock-based compensation | 436.46 Thousand | 1.15 Million | 214.39 Thousand | 944.72 Thousand | - | 1.67 Million |
| Change in working capital | -694.24 Thousand | 3.44 Million | 838.94 Thousand | 3.19 Million | -325.07 Thousand | -104 Thousand |
| Other non-cash items | 1.81 Million | 3.43 Million | -1.45 Million | -294.5 Thousand | 1.92 Million | -1.63 Million |
| Investing Cash Flow | 5.24 Million | - | -5.24 Million | 7.36 Million | - | -2.36 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | -2.36 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 268.00 |
| Financing Cash Flow | 4.75 Million | 12.97 Million | 7.12 Million | 5.85 Million | 2.92 Million | 3.72 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 12.97 Million | - | - | - | 3.72 Million |
| Other Financing Activities | 4.75 Million | -3.00 | 7.12 Million | 5.85 Million | 2.92 Million | 3.72 Million |
| Accounts receivables | 274.61 Thousand | 3.44 Million | 4.09 Million | -650.15 Thousand | -325.07 Thousand | -6000.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -968.85 Thousand | -7000.00 | -3.26 Million | 3.84 Million | - | -98 Thousand |
| Cash at beginning of period | - | 7.36 Million | 4.39 Million | - | - | 27.58 Million |
| Cash at end of period | 3.56 Million | 5.24 Million | 425.33 Thousand | 4.39 Million | -1.48 Million | 7.36 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -96.37 Thousand | 64.24 Thousand | 79.55 Thousand | -15.31 Thousand | -7655.00 | 1.17 Million |
| Net cash flow / Change in cash | 3.56 Million | -2.11 Million | -3.96 Million | 4.39 Million | -1.48 Million | -20.22 Million |
| Free Cash Flow | -6.33 Million | -15.15 Million | -6.35 Million | -8.8 Million | -4.4 Million | -22.76 Million |
RTG
WTHVF
CBDX
NDLS
RWB
IBTN